Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs
The Journal of Infectious Diseases Sep 24, 2021
Ward KM, Falade-Nwulia O, Moon J, et al. - Despite poor adherence and substance use disorders (SUDs), treatment persistence resulted in high sustained virologic response (SVR) rates among HIV/HCV (hepatitis C virus) patients.
One hundred ten of the 144 participants with HIV/HCV and SUDs began a 12-week treatment course under one of three conditions (usual care, peer mentors, and cash incentives).
The majority of individuals (n = 105) continued treatment once it was initiated, with 95% (n = 100) reaching SVR.
By the biomarker phosphatidylethanol (PEth ≥ 50 ng/mL), one-third (34%) of patients reported moderate/heavy alcohol use, and 44% had urine toxicological positive for cocaine or heroin at recruitment.
The proportion of people with strong adherence was 72% (n = 76), while the number of people with low adherence was 28%.
Despite the fact that low adherence was related to moderate/heavy alcohol use by PEth, SVR did not differ according to adherence (p = 0.702), and the majority of individuals (97%) with low adherence attained SVR.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries